CROM Symposium Recording

VIEW FULL SCREEN
 

The objective of the CROM consortium is to develop guidelines to identify, develop, and validate appropriate consumer-reported outcome measures (CROM) to assess tobacco and nicotine-containing products for premarket assessment and post-market surveillance to meet regulatory requirements (see more information here).

Part of the mission of the CROM consortium is to be a recognized scientific authority on CROM-related methodologies and to promote the communication between researchers within industry and academia. To support this mission, the CROM consortium organizes a symposium once a year, with the goal of gathering researchers from various disciplines in industry and academia in order to favor knowledge sharing and dialogue on topics relevant for tobacco regulatory science.

This year, the virtual symposium focuses on survey methodology and will address multiple topics including cross-sectional and longitudinal survey design, implementation, analysis, and interpretation. The symposium will act as a forum to share and discuss best practice principles to design surveys and highlight some of the main challenges and opportunities that are in front of us.

Programme and Presenters

Part I:  Survey methodology: the big picture

• Adapting Web-push Survey Methods to Countries Throughout the World
  Don DILLMAN, PhD, Washington State University
• Reducing Measurement Error with Qualitative Research Before and After Designing and Finalizing a Survey
  David HARRIS, M.A., Insight & Measurement LCC

Part II:  Survey methodology in the context of tobacco regulatory science

• Evaluation of Tobacco Product Perception and Intention Data to Inform Tobacco Product Review
  Benjamin APELBERG, PhD, Center for Tobacco Products, U.S Food & Drug Administration
• Longitudinal Studies for Modified Risk Tobacco Products in Postmarket Surveillance Settings
  Hui CHENG, PhD and Brendan NOGGLE, MPH, Altria Client Services
• Design and Methods of the Adult JUUL Switching and Smoking Trajectories (ADJUSST)
  Nicholas GOLDENSON, PhD, JUUL Labs, Inc.

Q&A and Panel Discussion

• All presenters